A Clinical Study of Epilepsy Localization and Prognosis Based on PET and Resting-state fMRI

Not yet recruiting

• Conditions: Epileptic Seizure
• Interventions: Other: No intervention

• Registration Number: NCT05567042
• Lead Sponsor: Li Shuangshuang

Brief Summary

1. By following up the prognosis of surgical patients, the application value of Cortex ID quantitative analysis in the localization of epilepsy foci was studied.

2. By studying the correlation between autonomic nerve function and epilepsy neural network in epilepsy patients, and analyzing the differences between different epilepsy patients, it can provide more information for judging the prognosis of epilepsy patients.

Detailed Description

This study included diagnostic trials and case-control studies, which were observational studies with no intervention. First, the demographic and clinical information of epilepsy patients in the Neurology Department of Xijing Hospital were collected, including gender, age, age of onset, course of epilepsy, seizure performance before treatment, seizure frequency before treatment, type and dose of antiepileptic drugs, past history, Family history, etc., as well as imaging, EEG, quality of life, and neuropsychological assessment, etc. were collected; secondly, functional magnetic resonance imaging (fMRI) and 24-hour Holter monitoring were performed on patients who met the inclusion criteria. Positron Emission Computed Tomography (PET) images of patients who have undergone or plan to undergo surgery are analyzed; finally, appropriate statistical methods are used for analysis.

Study Timeline

• Study First Submitted: 2022-09-26
• Status Verified: 2022-10
• Study Start: 2022-10
• Study First Submitted QC: 2022-10-04
• Last Update Submitted: 2022-10-04
• Study First Posted: 2022-10-05
• Last Update Posted: 2022-10-05
• Primary Completion: 2023-12
• Study Completion: 2024-07

Recruitment & Eligibility

• Status: NOT_YET_RECRUITING
• Sex: All
• Target Recruitment: 50

Inclusion Criteria

Meet the diagnostic criteria for epilepsy,

• No contraindications for fMRI examination.
• The patient had no other heart and lung diseases except epilepsy.
• Patients and their families were aware of this study and signed informed consent.

Exclusion Criteria

• Patients with severe infection, cerebrovascular disease, malignant tumor and other systemic diseases that can affect the nervous system, and those with serious dysfunction of the heart, liver, kidney and other organs.
• Non-epileptic seizures such as syncope and hysteria.
• Pregnant or lactating women. Incomplete clinical data

Study & Design

• Study Type: OBSERVATIONAL
• Study Design: Not specified

Arm && Interventions

Group	Intervention	Description
drug-resistant epilepsy	No intervention	No intervention
Medication is effective	No intervention	No intervention

Primary Outcome Measures

Name	Time	Method
Seizure frequency	2022-2024
Seizure duration	2022-2024